In follow-up to the May 12th “Delivering Most Favored Nation Prescription Drug Pricing to American Patients” Executive Order, ...

President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

Meanwhile, drugmakers ramp up U.S. manufacturing investments to navigate policy shifts and protect supply chain resilience.

Cencora, Inc. (NYSE:COR) on Wednesday reported third-quarter 2025 sales increased 8.7% to $80.66 billion, beating the ...

Brazil has requested consultations at the World Trade Organization over tariffs imposed by U.S. President Donald Trump on the ...

Bio-Techne on Wednesday said it expects uncertainty related to U.S. President Donald Trump's tariff and academic funding policies to spill into its fiscal year 2026 and could create pressure on the ...

George Tidmarsh takes over temporarily at CBER following Vinay Prasad’s abrupt departure; Replimmune trial leaders protest ...

Our system provides the best of both worlds: development of new drugs and cheap options for most prescriptions. | Opinion ...

Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...

One of Trump's demands was that the CEOs' companies limit drug costs for states' Medicaid plans to "most-favored nation" ...

Albert Bourla confirmed that he called President Donald Trump after receiving a letter asking Pfizer and a clutch of other ...

The administration wants drugmakers to bring medication prices more closely in line with the Most-Favored Nation pricing approach.